1. Home
  2. STVN vs NOVT Comparison

STVN vs NOVT Comparison

Compare STVN & NOVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STVN
  • NOVT
  • Stock Information
  • Founded
  • STVN 1949
  • NOVT 1968
  • Country
  • STVN Italy
  • NOVT United States
  • Employees
  • STVN N/A
  • NOVT N/A
  • Industry
  • STVN Containers/Packaging
  • NOVT Industrial Machinery/Components
  • Sector
  • STVN Consumer Discretionary
  • NOVT Miscellaneous
  • Exchange
  • STVN Nasdaq
  • NOVT Nasdaq
  • Market Cap
  • STVN 5.7B
  • NOVT 5.1B
  • IPO Year
  • STVN 2021
  • NOVT N/A
  • Fundamental
  • Price
  • STVN $20.93
  • NOVT $128.09
  • Analyst Decision
  • STVN Buy
  • NOVT Hold
  • Analyst Count
  • STVN 7
  • NOVT 1
  • Target Price
  • STVN $26.93
  • NOVT $160.00
  • AVG Volume (30 Days)
  • STVN 372.3K
  • NOVT 220.0K
  • Earning Date
  • STVN 03-06-2025
  • NOVT 05-06-2025
  • Dividend Yield
  • STVN 0.28%
  • NOVT N/A
  • EPS Growth
  • STVN N/A
  • NOVT N/A
  • EPS
  • STVN 0.45
  • NOVT 1.77
  • Revenue
  • STVN $1,143,012,735.00
  • NOVT $949,245,000.00
  • Revenue This Year
  • STVN $8.60
  • NOVT $7.24
  • Revenue Next Year
  • STVN $12.43
  • NOVT $7.07
  • P/E Ratio
  • STVN $46.99
  • NOVT $72.03
  • Revenue Growth
  • STVN 1.72
  • NOVT 7.67
  • 52 Week Low
  • STVN $16.56
  • NOVT $125.42
  • 52 Week High
  • STVN $31.61
  • NOVT $187.12
  • Technical
  • Relative Strength Index (RSI)
  • STVN 50.35
  • NOVT 30.15
  • Support Level
  • STVN $20.11
  • NOVT $125.42
  • Resistance Level
  • STVN $21.21
  • NOVT $137.81
  • Average True Range (ATR)
  • STVN 1.00
  • NOVT 3.31
  • MACD
  • STVN -0.05
  • NOVT -0.65
  • Stochastic Oscillator
  • STVN 35.51
  • NOVT 11.95

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.

About NOVT Novanta Inc.

Novanta Inc manufactures photonic and motion-control components for original equipment manufacturers in the medical equipment and industrial technology markets. The firm operates in three segments: Precision Medicine and Manufacturing, Medical Solutions, and Robotics and Automation. It generates the majority of its revenue from the Medical Solutions segment that designs, manufactures, and markets a range of medical-grade technologies, including medical insufflators, pumps, and related disposables; visualization solutions; and wireless technologies. The firm generates the majority of its revenue from the United States and Europe.

Share on Social Networks: